CMS modifies anti-cancer compendia rules
Executive Summary
CMS slightly modifies the timeline for addition and deletion of compendia approved for use by Medicare Part B contractors in making local coverage decisions for off-label cancer drugs and biologicals from the 2008 proposed physician fee schedule update rule (1"The Pink Sheet" July 9, 2007, p. 13). According to the final rule, CMS will not publish an annual notice for formal requests to update the approved list of compendia, but will annually open a 30-day window on Jan. 15 for submissions. The agency says it expects to post submissions by March 15 on its Web site for a 30-day public notice and comment period...
You may also be interested in...
CMS Decisions On New Off-Label Chemotherapy Compendia Due By Early July
CMS will issue decisions by early July on the possible addition of four medical compendia as approved references for coverage of off-label uses of cancer drugs and biologicals
Part B Drug Compendia For Off-Label Chemotherapy May Be Updated Annually
CMS will annually solicit public comment on updating the list of compendia used by Medicare Part B contractors in making local coverage determinations for off-label cancer drugs and biologicals, according to a proposed rule scheduled for July 12 publication in the Federal Register
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.